local_hospital

Biotrial

Address
lock Available on a paid plan

Digestive System Diseases

At Biotrial in Rennes, this research area focuses on digestive system diseases such as non-alcoholic steatohepatitis and related liver conditions. The studies are designed to assess how new treatments behave in people with different liver function profiles and to support better treatment development.

  • Evaluating new therapies for non-alcoholic steatohepatitis
  • Studying treatment behavior in participants with hepatic impairment
  • Comparing responses in people with normal hepatic function and liver disease

These trials help improve understanding of liver-related conditions and how potential medicines may be used more safely and effectively.

Nervous System Diseases

This site is also running studies in nervous system diseases, with attention to conditions such as narcolepsy and cognitive impairment. The research is mainly aimed at testing new therapies and understanding their effects on safety, tolerability, and how the body processes them.

  • Investigating potential treatments for narcolepsy
  • Exploring approaches for cognitive impairment
  • Assessing safety and treatment response in neurological disorders

The work reflects a strong interest in developing better options for people affected by brain and nervous system conditions.

Psychiatry and Psychology

Clinical research in psychiatry and psychology at Unité Clinique includes studies in mental disorders such as schizophrenia and depression. These trials aim to evaluate new treatments and improve understanding of how they may support patients living with complex psychiatric conditions.

  • Testing therapies for schizophrenia
  • Exploring treatment options for depression
  • Measuring safety and potential benefit in mental health disorders

The research contributes to ongoing efforts to expand treatment choices in behavioral and mental health care.

Skin and Connective Tissue Diseases

Another active area covers skin and connective tissue diseases, including rare conditions such as Olmsted syndrome. The studies are focused on testing investigational therapies and learning more about how these diseases affect patients.

  • Evaluating new treatment options for Olmsted syndrome
  • Supporting research in rare dermatologic disorders
  • Assessing safety and tolerability in skin-related conditions

These trials help advance knowledge in uncommon diseases where treatment choices are often limited.

Female and Male Urogenital Diseases

Research in female urogenital diseases and male urogenital diseases includes conditions linked to kidney and urinary function, such as distal renal tubular acidosis. The trials are intended to evaluate candidate treatments and their effects in people with urogenital or renal disorders.

  • Studying therapies for distal renal tubular acidosis and related conditions
  • Assessing treatment effects in urogenital disorders
  • Examining safety and usefulness in renal disease research

This area supports clinical development for conditions affecting urinary tract and kidney health.

Healthy Volunteers and General Clinical Research

A large share of the studies at Biotrial involve healthy volunteers and participants with normal organ function, reflecting a strong early-stage research focus. These trials are used to test new therapies, understand how they are absorbed and tolerated, and compare them with placebo or food-related conditions.

  • Testing the safety and tolerability of new candidate treatments
  • Evaluating pharmacokinetics and how medicines behave in the body
  • Supporting early development of investigational therapies in healthy adults

This broad research activity helps move promising medicines forward before they are studied in specific diseases.

Unspecified Therapeutic Research

Some of the clinical work at the site falls into an unspecified category, showing that the Unité Clinique also supports exploratory studies across different medical needs. These trials are generally aimed at assessing whether new compounds are suitable for further clinical development.

  • Exploring investigational products with broader clinical potential
  • Supporting early evaluation of new therapies
  • Generating initial evidence to guide future research

This flexible research profile complements the site’s disease-focused studies and broadens its clinical trial portfolio.

Site Overview

assignment
16
connected trials
corporate_fare
14
sponsors
science
1
IMP

Activity Indicator

Last 6 months

2
Trials started
-50% vs previous period.
4
Trials started 6–12 months ago
16
Total trials linked
Highly Active
trending_downDeclining-50%
2
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
6
Sponsors (total)
14
Active sponsors
6

Sponsor Network

Top 6 by active trials.

lock +5 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +1 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
16
Outperforms 78% of sites
public
Therapeutic diversity
9areas
Outperforms 82% of sites
groups
Sponsor diversity
14sponsors
Outperforms 81% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Biotrial

lock Showing 1 of 16 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Phase I Study to Evaluate the Safety and Tolerability of Lu AH70212 and Lu AH69593 in Healthy Adults for the Treatment of NarcolepsyH. Lundbeck A/SPhase IRecruitingFeb 2026

IMP list

IMP Trials Status First start Last start
Lavender Oil1Unknown2023-08-312023-08-31

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.